Skip to main content
Impact of Missed and Late Meal Boluses on Glycemic Outcomes in Automated Insulin Delivery-Treated Children and Adolescents with Type 1 Diabetes: A Two-Center, Population-Based Cohort Study.
A NEW INDEX OF INSULIN SENSITIVITY FROM GLUCOSE SENSOR AND INSULIN PUMP DATA: IN SILICO AND IN VIVO VALIDATION IN YOUTHS WITH TYPE 1 DIABETES.
Insulin Replacement Across the Menstrual Cycle in Women with Type 1 Diabetes: An In-Silico Assessment of the Need for Ad-Hoc Technology.
Outpatient Randomized Crossover Comparison of Zone Model Predictive Control Automated Insulin Delivery with Weekly Data Driven Adaptation Versus Sensor-Augmented Pump: Results from the International Diabetes Closed-Loop Trial 4.
Glycemic Outcomes in Baseline Hemoglobin A1C Subgroups in the International Diabetes Closed-Loop Trial.
Patient-Reported Outcomes in a Randomized Trial of Closed-Loop Control: The Pivotal International Diabetes Closed-Loop Trial.
Youth with Type 1 Diabetes Had Improvement in Continuous Glucose Monitoring Metrics During the COVID-19 Pandemic.
Diabetes Technology and Therapy in the Pediatric Age Group.
Clinical Management and Pump Parameter Adjustment of the Control-IQ Closed-Loop Control System: Results from a 6-Month, Multicenter, Randomized Clinical Trial.
Predictors of Time-in-Range (70-180 mg/dL) Achieved Using a Closed-Loop Control System.